journal article·2024-12-31Open access

Recent advances in polysaccharide-based drug delivery systems for cancer therapy: a comprehensive review

Chou-Yi Hsu, Omer Qutaiba B. Allela, Ali M. Hussein, Mohammed Ahmed Mustafa, Mandeep Kaur, Mohd Alaraj, Ali Fawzi Al-Hussainy, Usama Kadem Radi, Mohammed Ubaid, Ameer Hassan Idan, Fahad Alsaikhan, Asghar Narmani, Bagher Farhood

Abstract

Cancer has a high rate of incidence and mortality throughout the world. Although several conventional approaches have been developed for the treatment of cancer, such as surgery, chemotherapy, radiotherapy and thermal therapy, they have remarkable disadvantages which result in inefficient treatment of cancer. For example, immunogenicity, prolonged treatment, non-specificity, metastasis and high cost of treatment, are considered as the major drawbacks of chemotherapy. Therefore, there is a fundamental requirement for the development of breakthrough technologies for cancer suppression. Polysaccharide-based drug delivery systems (DDSs) are the most reliable drug carriers for cancer therapy. Polysaccharides, as a kind of practical biomaterials, are divided into several types, including chitosan, alginates, dextran, hyaluronic acid, cyclodextrin, pectin, etc. Polysaccharides are extracted from different natural resources (like herbal, marine, microorganisms, etc.). The potential features of polysaccharides have made them reliable candidates for therapeutics delivery to cancer sites; the simple purification, ease of modification and functionalization, hydrophilicity, serum stability, appropriate drug loading capacity, biocompatibility, bioavailability, biodegradability and stimuli-responsive and sustained drug release manner are considerable aspects of these biopolymers. This review highlights the practical applications of polysaccharides-based DDSs in pharmaceutical science and cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Polysaccharides and Plant Cell Walls

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan City, Taiwan

Thunderbird School of Global Management, Arizona State University Tempe Campus, Phoenix, Arizona, USA

Department of Pharmacy, Al-Noor University College, Nineveh, Iraq

Department of Biomedical Sciences, College of Applied Sciences, Cihan University-Erbil, Kurdistan Region, Iraq

Department of Medical Laboratory Technology, University of Imam Jaafar AL-Sadiq, Iraq

Department of Chemistry, School of Sciences, Jain (Deemed-to-be) University, Bengaluru, India

Department of Sciences, Vivekananda Global University, Jaipur, India

Jerash Private University, Jerash, Jordan

College of Pharmacy, Ahl Al Bayt University, Kerbala, Iraq

Collage of Pharmacy, National University of Science and Technology, Dhi Qar, Iraq

Medical Technical College, Al-Farahidi University, Baghdad, Iraq

Al-Zahrawi University College, Karbala, Iraq

College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia

School of Pharmacy, Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia

Department of Life Science Engineering, University of Tehran, Tehran, Iran

Department of Medical Physics and Radiology, Kashan University of Medical Sciences, Kashan, Iran

References (100+)

Show source-provided references
1. 10.1016/j.carbpol.2021.11846410.1016/j.carbpol.2021.118464 ↗
2. 10.1016/j.canlet.2024.21681010.1016/j.canlet.2024.216810 ↗
3. 10.1016/j.carbpol.2023.12143410.1016/j.carbpol.2023.121434 ↗
4. 10.1016/j.jddst.2024.10556710.1016/j.jddst.2024.105567 ↗
5. 10.2147/IJN.S45115110.2147/IJN.S451151 ↗
6. 10.1007/s13534-022-00225-z10.1007/s13534-022-00225-z ↗
7. 10.1016/j.carbpol.2024.12183910.1016/j.carbpol.2024.121839 ↗
8. 10.1002/ijc.3474010.1002/ijc.34740 ↗
9. 10.3390/pharmaceutics1501022710.3390/pharmaceutics15010227 ↗
10. 10.1016/j.ijbiomac.2023.12639010.1016/j.ijbiomac.2023.126390 ↗
11. 10.1016/j.jddst.2023.10426610.1016/j.jddst.2023.104266 ↗
12. 10.3390/pharmaceutics1401001810.3390/pharmaceutics14010018 ↗
13. 10.1016/j.carbpol.2023.12069510.1016/j.carbpol.2023.120695 ↗
14. 10.1016/j.procbio.2021.09.00610.1016/j.procbio.2021.09.006 ↗
15. 10.1016/j.jddst.2024.10610410.1016/j.jddst.2024.106104 ↗
16. 10.1016/j.clinthera.2023.10.01610.1016/j.clinthera.2023.10.016 ↗
17. 10.1002/cncr.3521010.1002/cncr.35210 ↗
18. 10.1016/j.cis.2024.10326310.1016/j.cis.2024.103263 ↗
19. 10.1038/s41575-023-00856-210.1038/s41575-023-00856-2 ↗
20. 10.3322/caac.2166010.3322/caac.21660 ↗
21. 10.1016/j.ijbiomac.2023.12555410.1016/j.ijbiomac.2023.125554 ↗
22. 10.1016/j.nano.2023.10266210.1016/j.nano.2023.102662 ↗
23. 10.1016/j.critrevonc.2016.03.01410.1016/j.critrevonc.2016.03.014 ↗
24. 10.1080/1061186X.2017.138065510.1080/1061186X.2017.1380655 ↗
25. 10.1016/j.drudis.2016.11.00510.1016/j.drudis.2016.11.005 ↗
26. Menzin AW, King SA, Aikins JK, et al. Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer. Gynecol Oncol. 1994;54(1):103.
27. 10.1038/sj.bjc.660269810.1038/sj.bjc.6602698 ↗
28. 10.1016/j.ejon.2019.10168010.1016/j.ejon.2019.101680 ↗
29. 10.1080/17425247.2023.222394110.1080/17425247.2023.2223941 ↗
30. 10.1002/adfm.20230707410.1002/adfm.202307074 ↗
31. 10.1016/j.jconrel.2023.02.00910.1016/j.jconrel.2023.02.009 ↗
32. 10.1016/j.eurpolymj.2024.11283510.1016/j.eurpolymj.2024.112835 ↗
33. 10.1016/j.ijbiomac.2024.12954710.1016/j.ijbiomac.2024.129547 ↗
34. 10.1016/j.ijbiomac.2024.13507210.1016/j.ijbiomac.2024.135072 ↗
35. 10.1016/j.carbpol.2023.12144010.1016/j.carbpol.2023.121440 ↗
36. 10.1016/j.carres.2024.10907110.1016/j.carres.2024.109071 ↗
37. 10.1016/j.jconrel.2023.11.03610.1016/j.jconrel.2023.11.036 ↗
38. 10.3390/ijms2502078610.3390/ijms25020786 ↗
39. 10.1016/j.jddst.2024.10540110.1016/j.jddst.2024.105401 ↗
40. 10.1016/j.ijbiomac.2023.12776110.1016/j.ijbiomac.2023.127761 ↗
41. 10.3390/life1301020710.3390/life13010207 ↗
42. 10.3390/pharmaceutics1601008810.3390/pharmaceutics16010088 ↗
43. 10.1016/j.ijbiomac.2023.12870210.1016/j.ijbiomac.2023.128702 ↗
44. 10.1016/j.ijbiomac.2023.12433810.1016/j.ijbiomac.2023.124338 ↗
45. 10.1016/j.ijbiomac.2023.12509210.1016/j.ijbiomac.2023.125092 ↗
46. 10.3390/jfb1402005510.3390/jfb14020055 ↗
47. 10.1016/j.ijbiomac.2023.12702010.1016/j.ijbiomac.2023.127020 ↗
48. 10.3390/polym1511251010.3390/polym15112510 ↗
49. 10.1016/j.jconrel.2022.12.05110.1016/j.jconrel.2022.12.051 ↗
50. 10.1016/B978-0-12-817055-7.00018-210.1016/B978-0-12-817055-7.00018-2 ↗
51. 10.1016/B978-0-08-101997-9.00023-010.1016/B978-0-08-101997-9.00023-0 ↗
52. 10.1016/j.carbpol.2023.12158410.1016/j.carbpol.2023.121584 ↗
53. 10.1016/j.carbpol.2014.03.09910.1016/j.carbpol.2014.03.099 ↗
54. 10.1007/s40883-021-00207-010.1007/s40883-021-00207-0 ↗
55. 10.1016/j.ijbiomac.2023.12572710.1016/j.ijbiomac.2023.125727 ↗
56. 10.1016/j.jconrel.2021.02.01210.1016/j.jconrel.2021.02.012 ↗
57. 10.3390/antibiotics910064810.3390/antibiotics9100648 ↗
58. 10.1016/j.carbpol.2015.12.05310.1016/j.carbpol.2015.12.053 ↗
59. 10.1016/j.ijbiomac.2019.10.21610.1016/j.ijbiomac.2019.10.216 ↗
60. 10.1016/j.ijbiomac.2020.02.32510.1016/j.ijbiomac.2020.02.325 ↗
61. 10.1016/j.carbpol.2021.11783010.1016/j.carbpol.2021.117830 ↗
62. 10.1021/acs.biomac.9b0164410.1021/acs.biomac.9b01644 ↗
63. 10.1016/j.carpta.2023.10030810.1016/j.carpta.2023.100308 ↗
64. 10.3390/molecules2819698110.3390/molecules28196981 ↗
65. 10.1016/j.microc.2024.10994010.1016/j.microc.2024.109940 ↗
66. 10.3390/foods1306089110.3390/foods13060891 ↗
67. 10.1016/j.ijbiomac.2024.12993910.1016/j.ijbiomac.2024.129939 ↗
68. 10.1039/d0tb01713b10.1039/d0tb01713b ↗
69. 10.3389/fphar.2021.75300710.3389/fphar.2021.753007 ↗
70. 10.3390/molecules2417312210.3390/molecules24173122 ↗
71. 10.1016/j.ijbiomac.2024.13103510.1016/j.ijbiomac.2024.131035 ↗
72. 10.1016/j.ijbiomac.2024.13089110.1016/j.ijbiomac.2024.130891 ↗
73. 10.1016/j.ijbiomac.2024.13036410.1016/j.ijbiomac.2024.130364 ↗
74. 10.1016/j.colsurfb.2023.11363910.1016/j.colsurfb.2023.113639 ↗
75. 10.1016/j.biopha.2024.11633010.1016/j.biopha.2024.116330 ↗
76. 10.1021/acs.jafc.3c0838510.1021/acs.jafc.3c08385 ↗
77. 10.1016/j.biopha.2017.08.11810.1016/j.biopha.2017.08.118 ↗
78. 10.3389/fnut.2022.84608010.3389/fnut.2022.846080 ↗
79. 10.1007/s11095-024-03670-w10.1007/s11095-024-03670-w ↗
80. 10.1007/s13346-023-01417-510.1007/s13346-023-01417-5 ↗
81. 10.1016/j.jddst.2024.10552510.1016/j.jddst.2024.105525 ↗
82. 10.1016/j.ijbiomac.2023.12764310.1016/j.ijbiomac.2023.127643 ↗
83. 10.1016/j.ijbiomac.2021.12.09510.1016/j.ijbiomac.2021.12.095 ↗
84. 10.1016/j.pharmthera.2021.10792110.1016/j.pharmthera.2021.107921 ↗
85. 10.1016/j.carbpol.2020.11600210.1016/j.carbpol.2020.116002 ↗
86. 10.1016/j.carbpol.2024.12189710.1016/j.carbpol.2024.121897 ↗
87. 10.1016/j.carbpol.2024.12196210.1016/j.carbpol.2024.121962 ↗
88. 10.1016/j.ijbiomac.2024.13351810.1016/j.ijbiomac.2024.133518 ↗
89. 10.1007/s10126-024-10299-810.1007/s10126-024-10299-8 ↗
90. 10.3390/md2105030010.3390/md21050300 ↗
91. 10.1016/j.carbpol.2020.11602510.1016/j.carbpol.2020.116025 ↗
92. 10.1016/j.ijbiomac.2023.12881510.1016/j.ijbiomac.2023.128815 ↗
93. 10.1016/j.carbpol.2021.11809810.1016/j.carbpol.2021.118098 ↗
94. 10.1016/j.ijbiomac.2023.12727810.1016/j.ijbiomac.2023.127278 ↗
95. 10.1016/j.ijbiomac.2021.12.13010.1016/j.ijbiomac.2021.12.130 ↗
96. 10.1016/j.carbpol.2021.11882210.1016/j.carbpol.2021.118822 ↗
97. 10.1016/j.carpta.2024.10046910.1016/j.carpta.2024.100469 ↗
98. 10.1016/j.carbpol.2024.12238810.1016/j.carbpol.2024.122388 ↗
99. 10.1016/j.ijbiomac.2020.12.17710.1016/j.ijbiomac.2020.12.177 ↗
100. 10.1016/j.ijbiomac.2024.13068310.1016/j.ijbiomac.2024.130683 ↗